nodes	percent_of_prediction	percent_of_DWPC	metapath
Lubiprostone—CBR1—Doxorubicin—sarcoma	0.797	1	CbGbCtD
Lubiprostone—CLCN2—endothelium—sarcoma	0.0212	0.213	CbGeAlD
Lubiprostone—CLCN2—seminal vesicle—sarcoma	0.011	0.11	CbGeAlD
Lubiprostone—CLCN2—smooth muscle tissue—sarcoma	0.00917	0.0921	CbGeAlD
Lubiprostone—CLCN2—uterus—sarcoma	0.00787	0.079	CbGeAlD
Lubiprostone—CBR1—mammary gland—sarcoma	0.00685	0.0688	CbGeAlD
Lubiprostone—CLCN2—testis—sarcoma	0.00571	0.0573	CbGeAlD
Lubiprostone—CBR1—myometrium—sarcoma	0.00486	0.0488	CbGeAlD
Lubiprostone—CBR1—seminal vesicle—sarcoma	0.00439	0.0441	CbGeAlD
Lubiprostone—CLCN2—lymph node—sarcoma	0.00414	0.0415	CbGeAlD
Lubiprostone—CBR1—skin of body—sarcoma	0.00363	0.0364	CbGeAlD
Lubiprostone—CBR1—cardiac atrium—sarcoma	0.00317	0.0318	CbGeAlD
Lubiprostone—CBR1—uterus—sarcoma	0.00315	0.0317	CbGeAlD
Lubiprostone—CBR1—lymphoid tissue—sarcoma	0.00294	0.0295	CbGeAlD
Lubiprostone—CBR1—tendon—sarcoma	0.00276	0.0277	CbGeAlD
Lubiprostone—CBR1—bone marrow—sarcoma	0.00268	0.0269	CbGeAlD
Lubiprostone—CBR1—testis—sarcoma	0.00229	0.023	CbGeAlD
Lubiprostone—CBR1—liver—sarcoma	0.00216	0.0217	CbGeAlD
Lubiprostone—CBR1—lymph node—sarcoma	0.00166	0.0167	CbGeAlD
Lubiprostone—Mediastinal disorder—Vincristine—sarcoma	0.000581	0.00564	CcSEcCtD
Lubiprostone—Eructation—Epirubicin—sarcoma	0.000572	0.00556	CcSEcCtD
Lubiprostone—Malaise—Dactinomycin—sarcoma	0.000566	0.0055	CcSEcCtD
Lubiprostone—Mental disorder—Vincristine—sarcoma	0.000564	0.00548	CcSEcCtD
Lubiprostone—Cough—Thiotepa—sarcoma	0.000552	0.00536	CcSEcCtD
Lubiprostone—Erythema—Mitoxantrone—sarcoma	0.000546	0.0053	CcSEcCtD
Lubiprostone—Myalgia—Thiotepa—sarcoma	0.000538	0.00523	CcSEcCtD
Lubiprostone—Anxiety—Thiotepa—sarcoma	0.000537	0.00521	CcSEcCtD
Lubiprostone—Dysgeusia—Mitoxantrone—sarcoma	0.000535	0.00519	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.000535	0.00519	CcSEcCtD
Lubiprostone—Myalgia—Dactinomycin—sarcoma	0.000534	0.00519	CcSEcCtD
Lubiprostone—Eructation—Doxorubicin—sarcoma	0.00053	0.00514	CcSEcCtD
Lubiprostone—Discomfort—Dactinomycin—sarcoma	0.000528	0.00513	CcSEcCtD
Lubiprostone—Oedema—Dactinomycin—sarcoma	0.000512	0.00498	CcSEcCtD
Lubiprostone—Ill-defined disorder—Mitoxantrone—sarcoma	0.000507	0.00492	CcSEcCtD
Lubiprostone—Nervous system disorder—Thiotepa—sarcoma	0.000506	0.00492	CcSEcCtD
Lubiprostone—Tachycardia—Thiotepa—sarcoma	0.000504	0.00489	CcSEcCtD
Lubiprostone—Skin disorder—Thiotepa—sarcoma	0.000501	0.00487	CcSEcCtD
Lubiprostone—Malaise—Mitoxantrone—sarcoma	0.000493	0.00478	CcSEcCtD
Lubiprostone—Anorexia—Thiotepa—sarcoma	0.000492	0.00478	CcSEcCtD
Lubiprostone—Anorexia—Dactinomycin—sarcoma	0.000488	0.00474	CcSEcCtD
Lubiprostone—Myalgia—Vincristine—sarcoma	0.000477	0.00464	CcSEcCtD
Lubiprostone—Cough—Mitoxantrone—sarcoma	0.000477	0.00463	CcSEcCtD
Lubiprostone—Mediastinal disorder—Etoposide—sarcoma	0.00047	0.00457	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00047	0.00457	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000467	0.00453	CcSEcCtD
Lubiprostone—Chest pain—Mitoxantrone—sarcoma	0.000465	0.00452	CcSEcCtD
Lubiprostone—Myalgia—Mitoxantrone—sarcoma	0.000465	0.00452	CcSEcCtD
Lubiprostone—Anxiety—Mitoxantrone—sarcoma	0.000463	0.0045	CcSEcCtD
Lubiprostone—Discomfort—Mitoxantrone—sarcoma	0.000459	0.00446	CcSEcCtD
Lubiprostone—Oedema—Vincristine—sarcoma	0.000458	0.00445	CcSEcCtD
Lubiprostone—Dyspepsia—Thiotepa—sarcoma	0.000454	0.00441	CcSEcCtD
Lubiprostone—Nervous system disorder—Vincristine—sarcoma	0.000449	0.00436	CcSEcCtD
Lubiprostone—Decreased appetite—Thiotepa—sarcoma	0.000449	0.00436	CcSEcCtD
Lubiprostone—Oedema—Mitoxantrone—sarcoma	0.000446	0.00433	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Thiotepa—sarcoma	0.000446	0.00433	CcSEcCtD
Lubiprostone—Decreased appetite—Dactinomycin—sarcoma	0.000445	0.00432	CcSEcCtD
Lubiprostone—Fatigue—Thiotepa—sarcoma	0.000445	0.00432	CcSEcCtD
Lubiprostone—Dysgeusia—Etoposide—sarcoma	0.000445	0.00432	CcSEcCtD
Lubiprostone—Hyperhidrosis—Vincristine—sarcoma	0.000443	0.0043	CcSEcCtD
Lubiprostone—Fatigue—Dactinomycin—sarcoma	0.000442	0.00429	CcSEcCtD
Lubiprostone—Constipation—Thiotepa—sarcoma	0.000441	0.00429	CcSEcCtD
Lubiprostone—Pain—Thiotepa—sarcoma	0.000441	0.00429	CcSEcCtD
Lubiprostone—Shock—Mitoxantrone—sarcoma	0.000439	0.00426	CcSEcCtD
Lubiprostone—Pain—Dactinomycin—sarcoma	0.000438	0.00425	CcSEcCtD
Lubiprostone—Muscle spasms—Etoposide—sarcoma	0.000437	0.00424	CcSEcCtD
Lubiprostone—Anorexia—Vincristine—sarcoma	0.000436	0.00424	CcSEcCtD
Lubiprostone—Tachycardia—Mitoxantrone—sarcoma	0.000435	0.00422	CcSEcCtD
Lubiprostone—Skin disorder—Mitoxantrone—sarcoma	0.000433	0.0042	CcSEcCtD
Lubiprostone—Lethargy—Epirubicin—sarcoma	0.000432	0.00419	CcSEcCtD
Lubiprostone—Hyperhidrosis—Mitoxantrone—sarcoma	0.000431	0.00418	CcSEcCtD
Lubiprostone—Feeling abnormal—Thiotepa—sarcoma	0.000425	0.00413	CcSEcCtD
Lubiprostone—Anorexia—Mitoxantrone—sarcoma	0.000425	0.00413	CcSEcCtD
Lubiprostone—Feeling abnormal—Dactinomycin—sarcoma	0.000422	0.0041	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Thiotepa—sarcoma	0.000422	0.0041	CcSEcCtD
Lubiprostone—Ill-defined disorder—Etoposide—sarcoma	0.000422	0.00409	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Dactinomycin—sarcoma	0.000419	0.00407	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Vincristine—sarcoma	0.000417	0.00405	CcSEcCtD
Lubiprostone—Malaise—Etoposide—sarcoma	0.00041	0.00398	CcSEcCtD
Lubiprostone—Abdominal pain—Thiotepa—sarcoma	0.000408	0.00396	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000406	0.00394	CcSEcCtD
Lubiprostone—Abdominal pain—Dactinomycin—sarcoma	0.000405	0.00393	CcSEcCtD
Lubiprostone—Loss of consciousness—Etoposide—sarcoma	0.000399	0.00388	CcSEcCtD
Lubiprostone—Lethargy—Doxorubicin—sarcoma	0.000399	0.00388	CcSEcCtD
Lubiprostone—Decreased appetite—Vincristine—sarcoma	0.000398	0.00386	CcSEcCtD
Lubiprostone—Dyspnoea—Mitoxantrone—sarcoma	0.000397	0.00386	CcSEcCtD
Lubiprostone—Cough—Etoposide—sarcoma	0.000396	0.00385	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Vincristine—sarcoma	0.000395	0.00384	CcSEcCtD
Lubiprostone—Fatigue—Vincristine—sarcoma	0.000395	0.00383	CcSEcCtD
Lubiprostone—Dyspepsia—Mitoxantrone—sarcoma	0.000392	0.00381	CcSEcCtD
Lubiprostone—Pain—Vincristine—sarcoma	0.000391	0.0038	CcSEcCtD
Lubiprostone—Constipation—Vincristine—sarcoma	0.000391	0.0038	CcSEcCtD
Lubiprostone—Decreased appetite—Mitoxantrone—sarcoma	0.000388	0.00376	CcSEcCtD
Lubiprostone—Chest pain—Etoposide—sarcoma	0.000387	0.00376	CcSEcCtD
Lubiprostone—Fatigue—Mitoxantrone—sarcoma	0.000384	0.00373	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000384	0.00373	CcSEcCtD
Lubiprostone—Discomfort—Etoposide—sarcoma	0.000382	0.00371	CcSEcCtD
Lubiprostone—Pain—Mitoxantrone—sarcoma	0.000381	0.0037	CcSEcCtD
Lubiprostone—Constipation—Mitoxantrone—sarcoma	0.000381	0.0037	CcSEcCtD
Lubiprostone—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000381	0.0037	CcSEcCtD
Lubiprostone—Hypersensitivity—Thiotepa—sarcoma	0.00038	0.00369	CcSEcCtD
Lubiprostone—Hypersensitivity—Dactinomycin—sarcoma	0.000377	0.00367	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Vincristine—sarcoma	0.000374	0.00363	CcSEcCtD
Lubiprostone—Gastritis—Epirubicin—sarcoma	0.000374	0.00363	CcSEcCtD
Lubiprostone—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000373	0.00362	CcSEcCtD
Lubiprostone—Asthenia—Thiotepa—sarcoma	0.00037	0.0036	CcSEcCtD
Lubiprostone—Abdominal distension—Epirubicin—sarcoma	0.000368	0.00357	CcSEcCtD
Lubiprostone—Asthenia—Dactinomycin—sarcoma	0.000368	0.00357	CcSEcCtD
Lubiprostone—Feeling abnormal—Mitoxantrone—sarcoma	0.000367	0.00357	CcSEcCtD
Lubiprostone—Influenza—Epirubicin—sarcoma	0.000366	0.00355	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000365	0.00354	CcSEcCtD
Lubiprostone—Tachycardia—Etoposide—sarcoma	0.000362	0.00351	CcSEcCtD
Lubiprostone—Abdominal pain—Vincristine—sarcoma	0.000362	0.00351	CcSEcCtD
Lubiprostone—Skin disorder—Etoposide—sarcoma	0.00036	0.0035	CcSEcCtD
Lubiprostone—Hyperhidrosis—Etoposide—sarcoma	0.000358	0.00348	CcSEcCtD
Lubiprostone—Anorexia—Etoposide—sarcoma	0.000353	0.00343	CcSEcCtD
Lubiprostone—Diarrhoea—Thiotepa—sarcoma	0.000353	0.00343	CcSEcCtD
Lubiprostone—Abdominal pain—Mitoxantrone—sarcoma	0.000352	0.00342	CcSEcCtD
Lubiprostone—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000352	0.00342	CcSEcCtD
Lubiprostone—Diarrhoea—Dactinomycin—sarcoma	0.000351	0.0034	CcSEcCtD
Lubiprostone—Gastritis—Doxorubicin—sarcoma	0.000346	0.00336	CcSEcCtD
Lubiprostone—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000345	0.00335	CcSEcCtD
Lubiprostone—Dizziness—Thiotepa—sarcoma	0.000341	0.00331	CcSEcCtD
Lubiprostone—Abdominal distension—Doxorubicin—sarcoma	0.00034	0.00331	CcSEcCtD
Lubiprostone—Influenza—Doxorubicin—sarcoma	0.000338	0.00328	CcSEcCtD
Lubiprostone—Pollakiuria—Epirubicin—sarcoma	0.000338	0.00328	CcSEcCtD
Lubiprostone—Hypersensitivity—Vincristine—sarcoma	0.000337	0.00327	CcSEcCtD
Lubiprostone—Weight increased—Epirubicin—sarcoma	0.000333	0.00323	CcSEcCtD
Lubiprostone—Dyspnoea—Etoposide—sarcoma	0.000331	0.00321	CcSEcCtD
Lubiprostone—Hypersensitivity—Mitoxantrone—sarcoma	0.000328	0.00319	CcSEcCtD
Lubiprostone—Asthenia—Vincristine—sarcoma	0.000328	0.00319	CcSEcCtD
Lubiprostone—Vomiting—Thiotepa—sarcoma	0.000328	0.00319	CcSEcCtD
Lubiprostone—Vomiting—Dactinomycin—sarcoma	0.000326	0.00316	CcSEcCtD
Lubiprostone—Rash—Thiotepa—sarcoma	0.000325	0.00316	CcSEcCtD
Lubiprostone—Dermatitis—Thiotepa—sarcoma	0.000325	0.00316	CcSEcCtD
Lubiprostone—Headache—Thiotepa—sarcoma	0.000323	0.00314	CcSEcCtD
Lubiprostone—Rash—Dactinomycin—sarcoma	0.000323	0.00314	CcSEcCtD
Lubiprostone—Decreased appetite—Etoposide—sarcoma	0.000322	0.00313	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Etoposide—sarcoma	0.00032	0.00311	CcSEcCtD
Lubiprostone—Asthenia—Mitoxantrone—sarcoma	0.00032	0.00311	CcSEcCtD
Lubiprostone—Fatigue—Etoposide—sarcoma	0.00032	0.0031	CcSEcCtD
Lubiprostone—Pain—Etoposide—sarcoma	0.000317	0.00308	CcSEcCtD
Lubiprostone—Constipation—Etoposide—sarcoma	0.000317	0.00308	CcSEcCtD
Lubiprostone—Urinary tract infection—Epirubicin—sarcoma	0.000317	0.00308	CcSEcCtD
Lubiprostone—Diarrhoea—Vincristine—sarcoma	0.000313	0.00304	CcSEcCtD
Lubiprostone—Pollakiuria—Doxorubicin—sarcoma	0.000312	0.00303	CcSEcCtD
Lubiprostone—Weight increased—Doxorubicin—sarcoma	0.000308	0.00299	CcSEcCtD
Lubiprostone—Nausea—Thiotepa—sarcoma	0.000307	0.00298	CcSEcCtD
Lubiprostone—Feeling abnormal—Etoposide—sarcoma	0.000306	0.00297	CcSEcCtD
Lubiprostone—Diarrhoea—Mitoxantrone—sarcoma	0.000305	0.00296	CcSEcCtD
Lubiprostone—Nausea—Dactinomycin—sarcoma	0.000304	0.00296	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Etoposide—sarcoma	0.000303	0.00294	CcSEcCtD
Lubiprostone—Dizziness—Vincristine—sarcoma	0.000303	0.00294	CcSEcCtD
Lubiprostone—Abdominal pain—Etoposide—sarcoma	0.000293	0.00285	CcSEcCtD
Lubiprostone—Urinary tract infection—Doxorubicin—sarcoma	0.000293	0.00285	CcSEcCtD
Lubiprostone—Vomiting—Vincristine—sarcoma	0.000291	0.00283	CcSEcCtD
Lubiprostone—Rash—Vincristine—sarcoma	0.000289	0.0028	CcSEcCtD
Lubiprostone—Dermatitis—Vincristine—sarcoma	0.000288	0.0028	CcSEcCtD
Lubiprostone—Oedema peripheral—Epirubicin—sarcoma	0.000288	0.0028	CcSEcCtD
Lubiprostone—Connective tissue disorder—Epirubicin—sarcoma	0.000287	0.00279	CcSEcCtD
Lubiprostone—Headache—Vincristine—sarcoma	0.000287	0.00278	CcSEcCtD
Lubiprostone—Vomiting—Mitoxantrone—sarcoma	0.000283	0.00275	CcSEcCtD
Lubiprostone—Rash—Mitoxantrone—sarcoma	0.000281	0.00273	CcSEcCtD
Lubiprostone—Dermatitis—Mitoxantrone—sarcoma	0.000281	0.00273	CcSEcCtD
Lubiprostone—Headache—Mitoxantrone—sarcoma	0.000279	0.00271	CcSEcCtD
Lubiprostone—Hypersensitivity—Etoposide—sarcoma	0.000273	0.00265	CcSEcCtD
Lubiprostone—Nausea—Vincristine—sarcoma	0.000272	0.00264	CcSEcCtD
Lubiprostone—Oedema peripheral—Doxorubicin—sarcoma	0.000267	0.00259	CcSEcCtD
Lubiprostone—Asthenia—Etoposide—sarcoma	0.000266	0.00258	CcSEcCtD
Lubiprostone—Connective tissue disorder—Doxorubicin—sarcoma	0.000266	0.00258	CcSEcCtD
Lubiprostone—Nausea—Mitoxantrone—sarcoma	0.000265	0.00257	CcSEcCtD
Lubiprostone—Mediastinal disorder—Epirubicin—sarcoma	0.000264	0.00256	CcSEcCtD
Lubiprostone—Mental disorder—Epirubicin—sarcoma	0.000256	0.00249	CcSEcCtD
Lubiprostone—Erythema—Epirubicin—sarcoma	0.000255	0.00247	CcSEcCtD
Lubiprostone—Malnutrition—Epirubicin—sarcoma	0.000255	0.00247	CcSEcCtD
Lubiprostone—Diarrhoea—Etoposide—sarcoma	0.000254	0.00246	CcSEcCtD
Lubiprostone—Flatulence—Epirubicin—sarcoma	0.000251	0.00244	CcSEcCtD
Lubiprostone—Dysgeusia—Epirubicin—sarcoma	0.000249	0.00242	CcSEcCtD
Lubiprostone—Dizziness—Etoposide—sarcoma	0.000245	0.00238	CcSEcCtD
Lubiprostone—Muscle spasms—Epirubicin—sarcoma	0.000245	0.00238	CcSEcCtD
Lubiprostone—Mediastinal disorder—Doxorubicin—sarcoma	0.000244	0.00237	CcSEcCtD
Lubiprostone—Mental disorder—Doxorubicin—sarcoma	0.000237	0.0023	CcSEcCtD
Lubiprostone—Ill-defined disorder—Epirubicin—sarcoma	0.000236	0.00229	CcSEcCtD
Lubiprostone—Vomiting—Etoposide—sarcoma	0.000236	0.00229	CcSEcCtD
Lubiprostone—Malnutrition—Doxorubicin—sarcoma	0.000236	0.00229	CcSEcCtD
Lubiprostone—Erythema—Doxorubicin—sarcoma	0.000236	0.00229	CcSEcCtD
Lubiprostone—Rash—Etoposide—sarcoma	0.000234	0.00227	CcSEcCtD
Lubiprostone—Dermatitis—Etoposide—sarcoma	0.000234	0.00227	CcSEcCtD
Lubiprostone—Headache—Etoposide—sarcoma	0.000232	0.00226	CcSEcCtD
Lubiprostone—Flatulence—Doxorubicin—sarcoma	0.000232	0.00225	CcSEcCtD
Lubiprostone—Dysgeusia—Doxorubicin—sarcoma	0.000231	0.00224	CcSEcCtD
Lubiprostone—Malaise—Epirubicin—sarcoma	0.00023	0.00223	CcSEcCtD
Lubiprostone—Syncope—Epirubicin—sarcoma	0.000228	0.00222	CcSEcCtD
Lubiprostone—Muscle spasms—Doxorubicin—sarcoma	0.000227	0.0022	CcSEcCtD
Lubiprostone—Palpitations—Epirubicin—sarcoma	0.000225	0.00219	CcSEcCtD
Lubiprostone—Loss of consciousness—Epirubicin—sarcoma	0.000224	0.00217	CcSEcCtD
Lubiprostone—Cough—Epirubicin—sarcoma	0.000222	0.00216	CcSEcCtD
Lubiprostone—Nausea—Etoposide—sarcoma	0.00022	0.00214	CcSEcCtD
Lubiprostone—Ill-defined disorder—Doxorubicin—sarcoma	0.000219	0.00212	CcSEcCtD
Lubiprostone—Chest pain—Epirubicin—sarcoma	0.000217	0.00211	CcSEcCtD
Lubiprostone—Myalgia—Epirubicin—sarcoma	0.000217	0.00211	CcSEcCtD
Lubiprostone—Anxiety—Epirubicin—sarcoma	0.000216	0.0021	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000215	0.00209	CcSEcCtD
Lubiprostone—Discomfort—Epirubicin—sarcoma	0.000214	0.00208	CcSEcCtD
Lubiprostone—Malaise—Doxorubicin—sarcoma	0.000213	0.00206	CcSEcCtD
Lubiprostone—Dry mouth—Epirubicin—sarcoma	0.000212	0.00206	CcSEcCtD
Lubiprostone—Syncope—Doxorubicin—sarcoma	0.000211	0.00205	CcSEcCtD
Lubiprostone—Palpitations—Doxorubicin—sarcoma	0.000208	0.00202	CcSEcCtD
Lubiprostone—Oedema—Epirubicin—sarcoma	0.000208	0.00202	CcSEcCtD
Lubiprostone—Loss of consciousness—Doxorubicin—sarcoma	0.000207	0.00201	CcSEcCtD
Lubiprostone—Cough—Doxorubicin—sarcoma	0.000206	0.002	CcSEcCtD
Lubiprostone—Shock—Epirubicin—sarcoma	0.000204	0.00199	CcSEcCtD
Lubiprostone—Nervous system disorder—Epirubicin—sarcoma	0.000204	0.00198	CcSEcCtD
Lubiprostone—Tachycardia—Epirubicin—sarcoma	0.000203	0.00197	CcSEcCtD
Lubiprostone—Skin disorder—Epirubicin—sarcoma	0.000202	0.00196	CcSEcCtD
Lubiprostone—Hyperhidrosis—Epirubicin—sarcoma	0.000201	0.00195	CcSEcCtD
Lubiprostone—Chest pain—Doxorubicin—sarcoma	0.000201	0.00195	CcSEcCtD
Lubiprostone—Myalgia—Doxorubicin—sarcoma	0.000201	0.00195	CcSEcCtD
Lubiprostone—Anxiety—Doxorubicin—sarcoma	0.0002	0.00194	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000199	0.00193	CcSEcCtD
Lubiprostone—Discomfort—Doxorubicin—sarcoma	0.000198	0.00192	CcSEcCtD
Lubiprostone—Anorexia—Epirubicin—sarcoma	0.000198	0.00192	CcSEcCtD
Lubiprostone—Dry mouth—Doxorubicin—sarcoma	0.000196	0.00191	CcSEcCtD
Lubiprostone—Oedema—Doxorubicin—sarcoma	0.000192	0.00187	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000189	0.00184	CcSEcCtD
Lubiprostone—Shock—Doxorubicin—sarcoma	0.000189	0.00184	CcSEcCtD
Lubiprostone—Nervous system disorder—Doxorubicin—sarcoma	0.000189	0.00183	CcSEcCtD
Lubiprostone—Tachycardia—Doxorubicin—sarcoma	0.000188	0.00182	CcSEcCtD
Lubiprostone—Skin disorder—Doxorubicin—sarcoma	0.000187	0.00181	CcSEcCtD
Lubiprostone—Hyperhidrosis—Doxorubicin—sarcoma	0.000186	0.00181	CcSEcCtD
Lubiprostone—Dyspnoea—Epirubicin—sarcoma	0.000185	0.0018	CcSEcCtD
Lubiprostone—Anorexia—Doxorubicin—sarcoma	0.000183	0.00178	CcSEcCtD
Lubiprostone—Dyspepsia—Epirubicin—sarcoma	0.000183	0.00178	CcSEcCtD
Lubiprostone—Decreased appetite—Epirubicin—sarcoma	0.000181	0.00175	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Epirubicin—sarcoma	0.000179	0.00174	CcSEcCtD
Lubiprostone—Fatigue—Epirubicin—sarcoma	0.000179	0.00174	CcSEcCtD
Lubiprostone—Pain—Epirubicin—sarcoma	0.000178	0.00173	CcSEcCtD
Lubiprostone—Constipation—Epirubicin—sarcoma	0.000178	0.00173	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000175	0.0017	CcSEcCtD
Lubiprostone—Dyspnoea—Doxorubicin—sarcoma	0.000171	0.00167	CcSEcCtD
Lubiprostone—Feeling abnormal—Epirubicin—sarcoma	0.000171	0.00166	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Epirubicin—sarcoma	0.00017	0.00165	CcSEcCtD
Lubiprostone—Dyspepsia—Doxorubicin—sarcoma	0.000169	0.00164	CcSEcCtD
Lubiprostone—Decreased appetite—Doxorubicin—sarcoma	0.000167	0.00162	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000166	0.00161	CcSEcCtD
Lubiprostone—Fatigue—Doxorubicin—sarcoma	0.000166	0.00161	CcSEcCtD
Lubiprostone—Constipation—Doxorubicin—sarcoma	0.000164	0.0016	CcSEcCtD
Lubiprostone—Pain—Doxorubicin—sarcoma	0.000164	0.0016	CcSEcCtD
Lubiprostone—Abdominal pain—Epirubicin—sarcoma	0.000164	0.0016	CcSEcCtD
Lubiprostone—Feeling abnormal—Doxorubicin—sarcoma	0.000158	0.00154	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Doxorubicin—sarcoma	0.000157	0.00153	CcSEcCtD
Lubiprostone—Hypersensitivity—Epirubicin—sarcoma	0.000153	0.00149	CcSEcCtD
Lubiprostone—Abdominal pain—Doxorubicin—sarcoma	0.000152	0.00148	CcSEcCtD
Lubiprostone—Asthenia—Epirubicin—sarcoma	0.000149	0.00145	CcSEcCtD
Lubiprostone—Diarrhoea—Epirubicin—sarcoma	0.000142	0.00138	CcSEcCtD
Lubiprostone—Hypersensitivity—Doxorubicin—sarcoma	0.000142	0.00138	CcSEcCtD
Lubiprostone—Asthenia—Doxorubicin—sarcoma	0.000138	0.00134	CcSEcCtD
Lubiprostone—Dizziness—Epirubicin—sarcoma	0.000137	0.00133	CcSEcCtD
Lubiprostone—Vomiting—Epirubicin—sarcoma	0.000132	0.00128	CcSEcCtD
Lubiprostone—Diarrhoea—Doxorubicin—sarcoma	0.000132	0.00128	CcSEcCtD
Lubiprostone—Rash—Epirubicin—sarcoma	0.000131	0.00127	CcSEcCtD
Lubiprostone—Dermatitis—Epirubicin—sarcoma	0.000131	0.00127	CcSEcCtD
Lubiprostone—Headache—Epirubicin—sarcoma	0.00013	0.00126	CcSEcCtD
Lubiprostone—Dizziness—Doxorubicin—sarcoma	0.000127	0.00124	CcSEcCtD
Lubiprostone—Nausea—Epirubicin—sarcoma	0.000123	0.0012	CcSEcCtD
Lubiprostone—Vomiting—Doxorubicin—sarcoma	0.000122	0.00119	CcSEcCtD
Lubiprostone—Rash—Doxorubicin—sarcoma	0.000121	0.00118	CcSEcCtD
Lubiprostone—Dermatitis—Doxorubicin—sarcoma	0.000121	0.00118	CcSEcCtD
Lubiprostone—Headache—Doxorubicin—sarcoma	0.00012	0.00117	CcSEcCtD
Lubiprostone—Nausea—Doxorubicin—sarcoma	0.000114	0.00111	CcSEcCtD
